BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Gemcitabine refractory
1
Multicenter phase Ⅱ trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer
12/14/2018 10:51:22 AM | Browse: 1024 | Download: 1510